Free Trial

Unicycive Therapeutics (UNCY) Institutional Ownership

Unicycive Therapeutics logo
$4.64 -0.01 (-0.11%)
Closing price 03:57 PM Eastern
Extended Trading
$4.64 0.00 (0.00%)
As of 04:19 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Unicycive Therapeutics (NASDAQ:UNCY)

Current
Institutional Ownership
Percentage
40.42%
Number of
Institutional Buyers
(last 12 months)
11
Total
Institutional Inflows
(last 12 months)
$192.17M
Number of
Institutional Sellers
(last 12 months)
6
Total
Institutional Outflows
(last 12 months)
$31.35M
Get UNCY Insider Trade Alerts

Want to know when executives and insiders are buying or selling Unicycive Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

UNCY Institutional Buying and Selling by Quarter

Unicycive Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/15/2025Nantahala Capital Management LLC9,391,994$5.40M0.2%-9.6%7.786%
5/14/2025Walleye Capital LLC4,094,256$2.35M0.0%-18.1%3.394%
5/12/2025Vivo Capital LLC11,370,152$6.54M0.9%+14.0%9.426%
5/8/2025XTX Topco Ltd123,233$71K0.0%-28.1%0.103%
2/17/2025Octagon Capital Advisors LP10,000,000$7.94M1.3%+16.8%9.634%
2/17/2025Alyeska Investment Group L.P.1,750,000$1.39M0.0%-22.2%1.686%
2/17/2025Acuta Capital Partners LLC2,303,000$1.83M1.8%+16.4%2.219%
2/14/2025Nantahala Capital Management LLC10,391,994$8.25M0.4%+268.5%10.012%
2/14/2025Northern Trust Corp58,181$46K0.0%+142.4%0.056%
2/14/2025Silverarc Capital Management LLC2,486,709$1.98M0.4%-37.8%2.396%
2/14/2025Vivo Capital LLC9,970,152$7.92M0.9%+123.0%9.605%
2/13/2025XTX Topco Ltd171,463$136K0.0%+142.2%0.165%
2/12/2025Geode Capital Management LLC524,487$417K0.0%+30.3%0.505%
11/20/2024Virtu Financial LLC73,975$30K0.0%+566.8%0.071%
11/15/2024XTX Topco Ltd70,784$29K0.0%N/A0.075%
11/14/2024Walleye Capital LLC5,000,000$2.04M0.0%N/A5.299%
11/14/2024Acuta Capital Partners LLC1,979,199$807K0.7%N/A2.097%
11/13/2024Great Point Partners LLC8,559,000$3.49M1.0%N/A9.071%
10/16/2024Bleakley Financial Group LLC80,000$33K0.0%N/A0.085%
8/20/2024Nantahala Capital Management LLC2,820,358$1.41M0.1%-15.4%7.499%
7/12/2024Rosalind Advisors Inc.1,571,200$787K0.6%-16.4%4.178%
5/20/2024Virtu Financial LLC26,082$36K0.0%N/A0.069%
5/16/2024BVF Inc. IL3,611,601$4.98M0.1%+70.5%9.603%
4/25/2024Rosalind Advisors Inc.1,879,646$2.59M2.4%N/A5.407%
2/15/2024BVF Inc. IL2,118,139$1.84M0.0%-37.9%6.095%
11/15/2023RA Capital Management L.P.3,470,688$2.99M0.1%N/A9.987%
11/8/2023Vivo Capital LLC3,470,152$2.98M0.4%N/A9.986%
8/10/2023Ground Swell Capital LLC20,001$26K0.1%N/A0.131%
4/26/2023Oxbow Advisors LLC11,861$25K0.0%N/A0.078%
2/15/2023Nantahala Capital Management LLC647,416$350K0.0%-8.9%4.302%
11/15/2022Board of Trustees of The Leland Stanford Junior University63,019$37K0.0%-74.5%0.419%
11/10/2022Nantahala Capital Management LLC710,542$419K0.0%-2.6%4.721%
8/15/2022Nantahala Capital Management LLC729,680$606K0.0%+13.9%4.855%
4/22/2022Truist Financial Corp37,462$48K0.0%N/A0.250%
11/12/2021Board of Trustees of The Leland Stanford Junior University247,583$700K0.1%N/A1.707%
11/9/2021BlackRock Inc.11,443$33K0.0%N/A0.079%
10/28/2021Tandem Capital Management Corp ADV15,500$44K0.0%N/A0.107%
(Data available from 1/1/2016 forward)

UNCY Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of UNCY shares?

During the previous two years, 17 institutional investors and hedge funds held shares of Unicycive Therapeutics. The most heavily invested institutionals were Octagon Capital Advisors LP ($7.94M), Vivo Capital LLC ($6.54M), Nantahala Capital Management LLC ($5.40M), BVF Inc. IL ($4.98M), Great Point Partners LLC ($3.49M), RA Capital Management L.P. ($2.99M), and Walleye Capital LLC ($2.35M).Learn more on Unicycive Therapeutics' institutional investors.

What percentage of Unicycive Therapeutics' stock is owned by institutional investors?

40.42% of Unicycive Therapeutics' stock is owned by institutional investors. Learn more on UNCY's institutional investor holdings.

Which institutional investors have been buying Unicycive Therapeutics' stock?

Of the 15 institutional investors that purchased Unicycive Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Vivo Capital LLC ($10.37M), Great Point Partners LLC ($8.56M), Nantahala Capital Management LLC ($7.57M), Walleye Capital LLC ($5M), RA Capital Management L.P. ($3.47M), Acuta Capital Partners LLC ($2.30M), and Rosalind Advisors Inc. ($1.88M).

How much institutional buying is happening at Unicycive Therapeutics?

Institutional investors have bought a total of 32,245,252 shares in the last 24 months. This purchase volume represents approximately $192.17M in transactions.

Which of Unicycive Therapeutics' major shareholders have been selling company stock?

The following institutional investors have sold Unicycive Therapeutics stock in the last 24 months: Nantahala Capital Management LLC ($1.52M), Silverarc Capital Management LLC ($1.51M), Walleye Capital LLC ($905.74K), Alyeska Investment Group L.P. ($500K), Rosalind Advisors Inc. ($308.45K), and XTX Topco Ltd ($48.23K).

How much institutional selling is happening at Unicycive Therapeutics?

Institutional investors have sold a total of 4,790,939 shares in the last 24 months. This volume of shares sold represents approximately $31.35M in transactions.



This page (NASDAQ:UNCY) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners